Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Почему макролиды эффективны при риносинуситах?
Почему макролиды эффективны при риносинуситах?
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Балмасова И.П., Еремина О.Ф., Гультяев М.М. и др. Иммунологические и аллергологические аспекты клинического применения макролидов. Рос. аллергол. журн. 2007; 3: 12–9.
2. Страчунский Л.С., Козлов С.Н. Макролиды в современной клинической практике. Смоленск: Русич, 1998.
3. Фомина И.П. Современные макролиды, особенности действия, значение в лечении бактериальных инфекций. Антибиотики и химиотерапия. 1995; 4: 47–56.
4. Amsden GW. Anti-inflammatory effects of macrolides – an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 2005; 55: 10–21.
5. Bosnar M, Kelneric Z, Munic V et al. Cellular Uptake and Efflux of Azithromycin, Erythromycin, Clarithromycin, Telithromycin, and Cethromycin. Antimicrob Agents Chemother 2005; 49: 2372–7.
6. Сervin A, Kalm O, Sandkull P et al. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effect on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 2002; 126: 481–9.
7. Cervin A, Wallwork B. Macrolide therapy of chronic rhinosinusitis. Rhinology 2007; 45 (4): 259–67.
8. Craig WA, Gudmundson S. Postantibiotic effect. In: Antibiotic in Laboratory Medicine. Ed.: V.Loran. Baltimore etc., 1996; p. 403–31.
9. Culik O, Eracovic V, Parnham MJ. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 2001; 429 (1–3): 209–29.
10. Gotfried MN. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004; 125: 52S–61S.
11. Desrosiers MY, Kilty SJ. Treatment alternatives for chronic rhinosinusitis persisting after ESS: what to do when antibiotics, steroids and surgery fail. Rhinology 2008; 46 (1): 3–14.
12. Fokkens W, Lund W, Mullol M. Europian Position Paper on Rhinosinusitis and Nasal polyps 2007. Rhinоlоgy 2007; Suppl. 20.
13. Hashiba M, Baba S. Efficacy of long-term administration of Clarythromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol 1996; 525 (Suppl.): 73–8.
14. Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 2010; 23 (3): 590–615.
15. Labro MT. Cellular ffects of macrolides on leukocyte function. Curr Pharm Design 2004; 10: 3067–80.
16. Lino Y, Sugita K, Toriyama M et al. Erythromycin therapy for otitis media with effusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg 1993; 119: 648–51.
17. Nalca Y, Jänsch L, Geffers R et al. Quorum-Sensing Antagonistic Activities of Azithromycin in Pseudomonas aeruginosa PAO1: a Global Approach. Antimicrob Agents Chemother 2006; 50: 1680–8.
18. Rhee CS, Majima Y, Arima S et al. Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic. Ann Otol Rhinol Laryngol 2000; 109: 484–7.
19. Rubin BK, Druce H, Ramires OE et al. Effect of Clarithromycin on nasal mucus properties in healthy sudjects and in patients with purulent rhinitis. Am J Respir Crit Care Med 1997; 155: 2018–23.
20. Wallwork B, Coman W, Mackay-Sim A et al. Effect of Clarithromycin on Nuclear Factor-KB and Transforming Growth Factor-B in Chronic Rhinosinusitis. Laryngoscope 2004; 114: 286–90.
21. Wozniak DJ, Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 2004; 125: 62S–69S.
2. Страчунский Л.С., Козлов С.Н. Макролиды в современной клинической практике. Смоленск: Русич, 1998.
3. Фомина И.П. Современные макролиды, особенности действия, значение в лечении бактериальных инфекций. Антибиотики и химиотерапия. 1995; 4: 47–56.
4. Amsden GW. Anti-inflammatory effects of macrolides – an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 2005; 55: 10–21.
5. Bosnar M, Kelneric Z, Munic V et al. Cellular Uptake and Efflux of Azithromycin, Erythromycin, Clarithromycin, Telithromycin, and Cethromycin. Antimicrob Agents Chemother 2005; 49: 2372–7.
6. Сervin A, Kalm O, Sandkull P et al. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effect on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 2002; 126: 481–9.
7. Cervin A, Wallwork B. Macrolide therapy of chronic rhinosinusitis. Rhinology 2007; 45 (4): 259–67.
8. Craig WA, Gudmundson S. Postantibiotic effect. In: Antibiotic in Laboratory Medicine. Ed.: V.Loran. Baltimore etc., 1996; p. 403–31.
9. Culik O, Eracovic V, Parnham MJ. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 2001; 429 (1–3): 209–29.
10. Gotfried MN. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004; 125: 52S–61S.
11. Desrosiers MY, Kilty SJ. Treatment alternatives for chronic rhinosinusitis persisting after ESS: what to do when antibiotics, steroids and surgery fail. Rhinology 2008; 46 (1): 3–14.
12. Fokkens W, Lund W, Mullol M. Europian Position Paper on Rhinosinusitis and Nasal polyps 2007. Rhinоlоgy 2007; Suppl. 20.
13. Hashiba M, Baba S. Efficacy of long-term administration of Clarythromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol 1996; 525 (Suppl.): 73–8.
14. Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 2010; 23 (3): 590–615.
15. Labro MT. Cellular ffects of macrolides on leukocyte function. Curr Pharm Design 2004; 10: 3067–80.
16. Lino Y, Sugita K, Toriyama M et al. Erythromycin therapy for otitis media with effusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg 1993; 119: 648–51.
17. Nalca Y, Jänsch L, Geffers R et al. Quorum-Sensing Antagonistic Activities of Azithromycin in Pseudomonas aeruginosa PAO1: a Global Approach. Antimicrob Agents Chemother 2006; 50: 1680–8.
18. Rhee CS, Majima Y, Arima S et al. Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic. Ann Otol Rhinol Laryngol 2000; 109: 484–7.
19. Rubin BK, Druce H, Ramires OE et al. Effect of Clarithromycin on nasal mucus properties in healthy sudjects and in patients with purulent rhinitis. Am J Respir Crit Care Med 1997; 155: 2018–23.
20. Wallwork B, Coman W, Mackay-Sim A et al. Effect of Clarithromycin on Nuclear Factor-KB and Transforming Growth Factor-B in Chronic Rhinosinusitis. Laryngoscope 2004; 114: 286–90.
21. Wozniak DJ, Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 2004; 125: 62S–69S.
Авторы
А.В.Варвянская, А.С.Лопатин
Кафедра болезней уха, горла и носа ГОУ ВПО Первого МГМУ им. И.М.Сеченова Минздравсоцразвития РФ
Кафедра болезней уха, горла и носа ГОУ ВПО Первого МГМУ им. И.М.Сеченова Минздравсоцразвития РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.